Working towards eradication of CV risk
Achieving LDL-c target, measurements of risk factors, and a need for tailored therapy choices are three important factors to reduce (residual) CV risk. Prof. Stroes briefly discusses these three topics.
Video navigation menu
- Achieving target LDL-c 0:08
- The risk factor Lp(a) 2:30
- Six pillars of (residual) CV risk 3:49
Prof. Erik Stroes, MD, PhD is professor of Vascular Medicine at Amsterdam University Medical Centers in Amsterdam, The Netherlands.
This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.